For men with low testosterone, the treatment conversation often defaults quickly to TRT. But for a significant proportion of men, particularly those who want to preserve natural function and fertility, enclomiphene offers a compelling alternative that is rarely discussed outside of specialist men's health settings.
What Is Enclomiphene?
Enclomiphene is the trans-isomer of clomiphene citrate (Clomid), a drug long used in female fertility medicine. As a selective oestrogen receptor modulator (SERM), enclomiphene blocks oestrogen receptors specifically at the hypothalamus and pituitary gland.
The clinical effect: by blocking oestrogen's negative feedback at these sites, enclomiphene removes the braking signal that suppresses GnRH, LH, and FSH release. The result is increased gonadotropin (LH and FSH) secretion from the pituitary, which drives the testes to produce more testosterone naturally.
Importantly, enclomiphene is the pure trans-isomer, unlike older clomiphene preparations that contained both cis and trans isomers. This refinement produces cleaner receptor modulation with fewer vision-related side effects associated with the cis-isomer.
How Does Enclomiphene Compare to TRT?
| Factor | Enclomiphene | TRT | |---|---|---| | Mechanism | Stimulates natural production via HPG axis | Delivers exogenous testosterone directly | | Effect on natural production | Stimulates and maintains | Suppresses endogenous production | | Effect on sperm count | Preserved or improved | Significantly reduced (often to zero) | | Effect on testicular size | Maintained | May reduce with prolonged use | | Time to testosterone normalisation | 4-8 weeks | 2-4 weeks | | Long-term commitment | Can be cycled or discontinued | Typically lifelong once started | | LH and FSH levels | Elevated (stimulated) | Suppressed | | Suitable for fertility preservation | Yes | Generally no |
Clinical Evidence for Enclomiphene
A Phase 3 clinical trial published in the Journal of Clinical Endocrinology and Metabolism compared enclomiphene to topical testosterone gel in hypogonadal men. Enclomiphene:
- Raised morning testosterone to the normal range (above 300 ng/dL) in over 90 percent of subjects
- Maintained elevated LH and FSH (confirming stimulation of natural production)
- Preserved sperm concentration, unlike the testosterone gel group (which saw a 40 percent reduction)
- Produced similar symptom improvement to the TRT arm
A subsequent study confirmed that enclomiphene maintains efficacy over 12 months without tachyphylaxis (loss of response over time).
Who Is Enclomiphene Best Suited For?
Enclomiphene is most appropriate for men who meet all of the following criteria:
- Secondary hypogonadism: Impaired pituitary or hypothalamic signalling, with the testes capable of producing testosterone if adequately stimulated (confirmed by LH and FSH levels)
- Intact testicular function: The Leydig cells must be capable of responding to LH stimulation
- Fertility priority: Men who want to maintain or improve sperm quality alongside testosterone
- Natural function preference: Men who want to stimulate rather than replace, particularly before committing to lifelong TRT
Enclomiphene is not appropriate for men with primary hypogonadism (testicular failure), where the testes cannot respond to LH stimulation regardless of how much pituitary drive is provided.
When TRT Is the More Appropriate Choice
TRT remains the first choice for:
- Confirmed primary hypogonadism
- Severe symptomatic hypogonadism where faster testosterone normalisation is clinically urgent
- Men who have previously tried enclomiphene or other stimulation protocols without adequate response
- Men who have completed family planning and are not concerned about fertility
The Longegra Approach: HPG Axis Assessment First
At Longegra, we test LH, FSH, and total and free testosterone together before recommending any testosterone intervention. This tells us whether your hypogonadism is primary (testes failing) or secondary (insufficient pituitary drive), which directly determines whether enclomiphene or TRT is the more appropriate starting point.
Frequently Asked Questions (FAQs)
Yes. Enclomiphene is available through physician-supervised compounding programs in India. Longegra prescribes enclomiphene as part of our testosterone optimisation protocols.
